Pro Share Advisors LLC Anavex Life Sciences Corp. Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,354 shares of AVXL stock, worth $63,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,354

Previous 20,330 14.64%

Holding current value

$63,168

Previous $187,000 17.65%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$8.44 - $13.41 $25,117 - $39,908	-2,976 Reduced 14.64%	17,354 $154,000
Q2 2025 Aug 07, 2025	BUY	$7.37 - $9.63 $1,835 - $2,397	249 Added 1.24%	20,330 $187,000
Q1 2025 May 08, 2025	SELL	$7.85 - $13.46 $39,768 - $68,188	-5,066 Reduced 20.15%	20,081 $172,000
Q4 2024 Feb 13, 2025	BUY	$5.11 - $12.56 $30,445 - $74,832	5,958 Added 31.05%	25,147 $270,000
Q3 2024 Nov 13, 2024	BUY	$4.11 - $7.04 $17,607 - $30,159	4,284 Added 28.74%	19,189 $108,000

Q2 2024 Aug 13, 2024	SELL	$3.39 - $5.02 $13,007 - $19,261	-3,837 Reduced 20.47%	14,905 $62,000
Q1 2024 May 08, 2024	BUY	$4.55 - $6.75 $6,970 - $10,341	1,532 Added 8.9%	18,742 $95,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $13,048 - $25,760	2,589 Added 17.71%	17,210 $160,000
Q3 2023 Nov 13, 2023	BUY	$6.55 - $9.37 $1,696 - $2,426	259 Added 1.8%	14,621 $95,000
Q2 2023 Aug 10, 2023	BUY	$7.66 - $9.5 $6,227 - $7,723	813 Added 6.0%	14,362 $116,000
Q1 2023 May 11, 2023	SELL	$8.32 - $11.75 $14,942 - $21,103	-1,796 Reduced 11.7%	13,549 $116,000
Q4 2022 Feb 02, 2023	BUY	$7.65 - $14.43 $8,912 - $16,810	1,165 Added 8.22%	15,345 $142,000
Q3 2022 Nov 04, 2022	BUY	$8.9 - $12.86 $4,325 - $6,249	486 Added 3.55%	14,180 $146,000
Q2 2022 Aug 01, 2022	SELL	$7.31 - $12.84 $49,466 - $86,888	-6,767 Reduced 33.07%	13,694 $136,000
Q1 2022 May 10, 2022	SELL	$9.74 - $17.69 $47,716 - $86,663	-4,899 Reduced 19.32%	20,461 $251,000
Q4 2021 Feb 08, 2022	BUY	$16.88 - $23.31 $428,076 - $591,141	25,360 New	25,360 $440,000
Q3 2021 Nov 12, 2021	SELL	$16.82 - $25.75 $270,802 - $414,575	-16,100 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.16 - $28.86 $4,724 - $13,419	465 Added 2.97%	16,100 $368,000
Q1 2021 May 14, 2021	BUY	$5.17 - $16.13 $20,711 - $64,616	4,006 Added 34.45%	15,635 $234,000
Q4 2020 Feb 09, 2021	BUY	$4.01 - $7.58 $46,632 - $88,147	11,629 New	11,629 $63,000

Others Institutions Holding AVXL

# of Institutions

211

Shares Held

32.2M

Call Options Held

1.82M

Put Options Held

1.09M

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $284M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Anavex Life Sciences Corp. Transaction History